Skye Bioscience Potential Upside

SKYE Stock  USD 0.90  0.05  5.88%   
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Skye Bioscience's current Potential Upside with peer comparisons and related risk metrics.

Current Potential Upside Value

With Potential Upside at 9.09, Skye Bioscience shows moderate estimated upside from current levels. Skye Bioscience trades below the model-derived fair value estimate by a meaningful margin.

Potential Upside

 = 

1PM

2PM

 = 
9.09
1PM = First upper moment
2PM = Second upper moment

Potential Upside Peers Comparison

Skye Bioscience's Potential Upside of 9.09 falls above the 8.06 peer average. Values range from 2.96 (Kezar Life Sciences) to 16.13 (PDS Biotechnology Corp), with wide dispersion across the group. Skye Bioscience shows greater estimated upside from current levels than the peer average.

Potential Upside Relative To Other Indicators

The chart below plots Potential Upside against Maximum Drawdown for Skye Bioscience and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
With Potential Upside at 9.09 and Maximum Drawdown at 26.15 , Skye Bioscience shows a 2.88 -to-one ratio between these indicators. This indicates Maximum Drawdown is significantly higher than Potential Upside for Skye Bioscience.
Compare Skye Bioscience to Peers

Methodology, Assumptions & Data Sources

The current Potential Upside for Skye Bioscience is 9.09. Skye Bioscience's Potential Upside is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.

Other Technical Indicators